Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Epoch Biosciences Inc.

Division of Elitech Group
www.epochbio.com

Latest From Epoch Biosciences Inc.

Appointments: Synthorx, BTG, Pertinax, Realm, Breath, Aerie, iOnctura, Inflazome and NBE

The week's round-up includes a new CEO at Synthorx Inc., new sales executives at Aerie Pharmaceuticals and board appointments at BTG, Pertinax Pharma, Realm Therapeutics, Breath Therapeutics, iOnctura, NBE Therapeutics and Inflazome.

Appointments BioPharmaceutical

Are stars finally aligning for Takeda in India?

Metabolic Disorders Dermatology

Vitae partner Boehringer takes BACE inhibitor into the clinic

Boehringer Ingelheim initiated a Phase I clinical trial for the beta-secretase (BACE) inhibitor developed under a 2009 collaboration agreement with Vitae Pharmaceuticals, triggering a $14m milestone payment to the private biopharma company.

Metabolic Disorders Neurology

Merck gets BACE boost in Alzheimer's race

Merck & Co's MK-8931 has successfully cleared an early hurdle in the race to find a product that might treat Alzheimer's disease through beta secretase enzyme (BACE) inhibition. The firm reported positive Phase Ib results showing a quick, dose-dependent reduction in amyloid.

Neurology Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Epoch Pharmaceuticals Inc.
  • Epoch Biosciences
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Elitech Group
  • Senior Management
  • William G Gerber, MD, CEO
    Bert W Hogue, CFO
    Sanford S Zweifach, Pres.
    Merl Hoekstra, PhD, VP, Corp. Dev.
  • Contact Info
  • Epoch Biosciences Inc.
    Phone: (425) 482-5555
    21720 23rd Dr. SE, #150
    Bothell, WA 98021
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register